Sinae Categoria Apis Factory

Active Pharmaceutical Ingredientia

Progestogen et estrogen
Product Name	Specificatio	Probatus	Cas No.
Progesterone	CP / EP / USP / JP	CEP / EU-GMP / FDA	57-83-0
Pregnenolone	In-domo	Kosher	145-13-1
Medroxyprogesterone ACETATE	CP / EP / USP / JP	Dmf / GMP	71-58-9
MESTERROL acetate	CP / EP / USP	Dmf in processususus	595-33-5
Mifepristone	CP / IP	Dmf / GMP	84371-65-3
Cyproterone acetate	CP / EP / IP / KP	CEP / TGA / EU-GMP	427-51-0
Levonorgestrel	CP / EP / USP / IP	CEP / GMP	797-63-7
Norethisterone	CP / EP / USP / JP	Dmf in processususus	68-22-4
Norethisterone acetate	EP / USP	Dmf in processususus	51-98-9
Norethisterone Enanthate	In-domo	Sub R & D	3836-23-5
Dripirenone	EP / USP	Dmf	67392-87-4
Gestodene	CP / Album	Dmf / GMP	60282-87-3
Estradiol	CP / EP / USP / KP	Dmf / GMP / WC	35380-71-3
Estriol	CP / EP / USP	Sub R & D	50-27- I
Ethinyl estradiol	CP / EP / USP	Gmp	57-63-6
Estradiol Valerate	CP / EP / USP / KP	Dmf	979-32-8
Estradiol cypionate	Usp	Dmf in processususus	313-06-4
Tubolone	CP / Album	Dmf / GMP	5630-53-5
Dienogest	Map	CEP / GMP	65928-58-7
Fullevestrant	EP / USP	Sub R & D	129453-61-8
Exemestane	CP / EP / USP	Sub R & D	107868-30-4

Androgen
Product Name	Specificatio	Probatus	Cas No.
Finasteride	CP / EP / USP	CEP / FDA / PMDA / GMP	98319-26-7
PRAESTITUTUM	EP / USP	CEP / FDA	164656-23-9
Abiratone acetate	CP / USP	Dmf / WC	154229-18-2
Darolutami	In-domo	Sub R & D	1297538-32-9
Testosterone	CP / EP / USP	CEP / WC / FDA	58-22-0
Testosterone undecanoate	CP	Dmf / WC	5949-44-0
Testosterone cypionate	Usp	Sub R & D	58-20-8
Testosterone enanthate	USP / JP	Sub R & D	315-37-7
Testosterone propionate	CP / EP / USP / JP	Sub R & D	57-85-2
DHEA (in pracers)	FP /In-domo	Dmf / WC / Kosher	53-43-0
Clascoterone	In-domo	Dmf in processususus	19608-29-8

Cortical hormone
Product Name	Specificatio	Probatus	Cas No.
Budesonide	CP / EP / USP / JP	CEP / FDA / GMP	51333-22-3
DESON	CP / USP	Dmf / GMP	638-94-8
Eplerenone	Map	CEP in processusus	107724-20-9
Methylprednisolone	CP / EP / USP / JP	Dmf / GMP	83-43-2
Methylprednisolone Hemisuccinate	CP / EP / USP	Dmf / GMP	2921-57-5
Fluticasone propionate	CP / EP / USP	Dmf	80474- 14-2
Fluticasone ira	CP / Album	Dmf in processususus	397864-44-7
Mometasone furoate	CP / EP / USP	Dmf in processususus	Anhydrous (83919-23-7) Monohydrate (141646-00-6)
Deflazacort	In-domo	Sub R & D	14484-47-0

Alii
Product Name	Specificatio	Probatus	Cas No.
Oxcarbazepine	CP / EP / USP / IP	CEP / FDA / GMP	28721-07-5
ESICARBAZEPAZIPAE ACETATE	CP / USP	Dmf	236395- 14-5
Ganciclovir	CP / EP / USP	Dmf / GMP	82410-32-0
VALCANCICLOVIR Hydrochloride	USP / Album	CEP in processus	175865-59-5
Oseltamivir phosphate	CP / EP / USP	Dmf	204255- 11-8
Baloxavir Marboxil	In-domo	Sub R & D	1985606-14-1
Revefenacin	In-domo	Dmf	864750-70-9
Mirabegron	CP / Album	Dmf	223673-61-8
Vibegron	In-domo	Sub R & D	1190389-15-1
Escitalopram oxalate	CP / EP / USP	Dmf in processusus	219861-08-2
Citalopram hydrobromide	CP / EP / USP	Dmf in processususus	59729-32-7
Cariprazine Hydrochloride	In-domo	Dmf	1083076-69-0
LASMIDITAN	In-domo	Dmf	439239-92-6
Luliconazole	In-domo	Dmf	187164-19-8
Apalutami	In-domo	Dmf	956104-40-8
Tadalafil	CP / EP / USP	Sub R & D	171596-29-5
Relugolix	In-domo	Dmf in processusus	737789-87-6
Phosphate Ruxolitinib	In-domo	Dmf in processususus	1092939-17-7
Abemaciclib	In-domo	Sub R & D	1231929-97-7
Phloroglucinol	CP / Album	Dmf	108-73-6
1,3,5, trimethoxybenzene	CP / in-Domus	Gmp	621-23-8
Ursodeoxycholic acidum	EP / USP / JP	Sub R & D	128-13-2
Tauroursodeoloxycholic acidum	In-domo	Sub R & D	14605-22-2
Cholesterol	CP / EP / USP / JP	Sub R & D	57-88-5
Omega-III-acidum ethyl aether XC	EP / USP	Dmf in processususus	-
Medium-torquem triglycerides	CP / USP / Album	Dmf	-
Benzalkonium chloride	USP / EP / JP	CEP in processusus	8001-54-5
Oleum (quia iniectio)	CP / USP / EP / JP	Dmf in processususus	8001-25-0
Ovum phospholipids (quia iniectio)	CP / USP / Album	Dmf	93685-90-6
Snack	In-domo	Dmf in processususus	203787-91-1

View as

Progesterone

Progesterone EP, USP, CP, JP, IP et KP specificationes habet.CEP in promptu sunt, EU-GMP,FDA approbavit.

CAS:57-83-0

Lege plus Mitte Inquisitionem

Finasteride

Finasteride EP, USP, CP, IP, JP in promptu habet, FDA, PMDA et GMP approbavit.

CAS:98319-26-7

Lege plus Mitte Inquisitionem

Budesonide

Budesonide habet USP, EP specificationes. CEP, GMP et FDA probatus est.

CAS:51333-22-3

Lege plus Mitte Inquisitionem

Dutasteride

Dutasteride EP, USP, CP, IP, JP specificationem habet. CEP et FDA praesto.

CAS:164656-23-9

Lege plus Mitte Inquisitionem

Desonide

Desonide USP et EP specificationes habet. DMF praesto.

CAS:638-94-8

Lege plus Mitte Inquisitionem

Methylprednisolone

Methylprednisolone specificationes USP, EP, IP, JP, KP habet. DMF and WC available.

CAS: 83-43-2

Lege plus Mitte Inquisitionem

<1 2 3 4 5...7 >

Humanwell Pharmaceuticus unus ex maximis API fabricandis in Sinis. Cum plusquam XX annos experientiae, APIs, intermediis et formulis elaboramus, fabricamus et mercaturas steroidales. Forum nostrum toto orbe terrarum operit, praesentias validas habemus in America Septentrionali, Europa, America Meridionali et Africa, cum fructibus plus quam 150 terris venditis.